Immunogenicity, reactogenicity and safety study of two different formulations of GSK Biologicals’ human rotavirus vaccine, Rotarix, in healthy infants

Trial Identifier: 116566
Sponsor: GlaxoSmithKline
Start Date: February 2019
Primary Completion Date: December 2019

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
India Bangalore, India, 560002
India Kolkata, India, 700017
India Ludhiana, India, 141 008
India Mumbai, India, 400012
India Pune, India, 411038
India Pune, India, 411 011
India Vellore, India, 632004
India Vellore,, India, 632002